Azitra to Carry Out 1-for-10 Reverse Stock Split on October 26
Biopharma Azitra (NYSE American: AZTR) will reverse split its shares 1-for-10 effective October 26, 2026, cutting shares outstanding to about 6.06 million.
- published
- in the api
- on the website
on the website stories appear 15 minutes after publication, in the api at once. connect the api →
what happened
Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company, said it intends to carry out a reverse stock split at a ratio of 1-for-10. The change takes effect at 12:01 a.m. Eastern Time on October 26, 2026, and the shares will trade on a split-adjusted basis from that day's market open under the same ticker, AZTR.
The number of issued shares will fall from 60,603,742 to about 6,060,374. Holders of fractional shares will receive cash based on the average closing price over the five trading days before the split. The board set the ratio within the range approved by shareholders at the June 15, 2026 meeting. The information was published by TradingView.
why it matters
A reverse split does not change a holder's stake in the company, but it raises the nominal share price, which can matter for listing requirements faced by low-priced stocks. For markets this is a company-specific corporate event that mainly concerns the company's own shareholders.
tags
instruments
sources
- Azitra, Inc. Announces Reverse Stock Split — ru.tradingview.com, 16 October 2026 at 12:00 UTC
- Moleculin Announces Reverse Stock Split — globenewswire.com, 16 October 2026 at 13:20 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
on the website stories appear 15 minutes after publication, in the api at once.
get stories in real time ↗